F.L. Putnam Investment Management’s Dyne Therapeutics DYN Stock Holding History

F.L. Putnam Investment Management’s Portfolio DYN Stock Details DYN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.18M	Buy	+52,975	New	+$985K	0.01%	350

Other funds holding DYN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

F.L. Putnam Investment Management's DYN Position: Q2 2026 in Review

F.L. Putnam Investment Management opened a new position in Dyne Therapeutics (DYN) in Q2 2026: 52,975 shares worth $1.18M. The stake represents 0.01% of the portfolio and ranks #350 among its holdings.

88 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

F.L. Putnam Investment Management held 52,975 shares of Dyne Therapeutics worth $1.18M as of Q2 2026.
Dyne Therapeutics was a new F.L. Putnam Investment Management position in Q2 2026.
Dyne Therapeutics made up 0.01% of F.L. Putnam Investment Management's portfolio in Q2 2026, its #350 holding.
88 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on F.L. Putnam Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.